2018
The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up
Hecht R, Hiebert L, Spearman WC, Sonderup MW, Guthrie T, Hallett TB, Nayagam S, Razavi H, Soe-Lin S, Vilakazi-Nhlapo K, Pillay Y, Resch S. The investment case for hepatitis B and C in South Africa: adaptation and innovation in policy analysis for disease program scale-up. Health Policy And Planning 2018, 33: 528-538. PMID: 29529282, PMCID: PMC5894072, DOI: 10.1093/heapol/czy018.Peer-Reviewed Original ResearchTransitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research
Resch S, Hecht R. Transitioning financial responsibility for health programs from external donors to developing countries: Key issues and recommendations for policy and research. Journal Of Global Health 2018, 8: 010301. PMID: 29391944, PMCID: PMC5782833, DOI: 10.7189/jogh.08.010301.Peer-Reviewed Original Research
2017
PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study
Cremin I, McKinnon L, Kimani J, Cherutich P, Gakii G, Muriuki F, Kripke K, Hecht R, Kiragu M, Smith J, Hinsley W, Gelmon L, Hallett TB. PrEP for key populations in combination HIV prevention in Nairobi: a mathematical modelling study. The Lancet HIV 2017, 4: e214-e222. PMID: 28233660, DOI: 10.1016/s2352-3018(17)30021-8.Peer-Reviewed Original ResearchConceptsFemale sex workersMale sex workersKey populationsAntiretroviral therapySex workersHigh-risk female sex workersEarly antiretroviral therapyPre-exposure prophylaxisCombination HIV preventionRisk of infectionSpecific key populationsWider populationPrEP interventionsTherapy retentionHIV incidenceCombination preventionHIV transmissionCondom promotionHIV epidemicHIV preventionIncidence estimatesMathematical modelling studyMale circumcisionPrEPAverage annual spendingReaching the global target to reduce stunting: an investment framework
Shekar M, Kakietek J, D’Alimonte M, Rogers H, Eberwein J, Akuoku J, Pereira A, Soe-Lin S, Hecht R. Reaching the global target to reduce stunting: an investment framework. Health Policy And Planning 2017, 32: 657-668. PMID: 28453717, PMCID: PMC5406759, DOI: 10.1093/heapol/czw184.Peer-Reviewed Original ResearchConceptsFinancial needsBurden-sharing rulesExample of HIVEconomic growthHuman capitalFinancing scenariosNecessary financingChildhood stuntingInvestment frameworkInternational financingCoordinated investmentAdult incomeBudget allocationFinancingSlower cognitive developmentMiddle-income countriesSustainable Development GoalsIncome countriesGlobal nutrition targetsLives Saved ToolDevelopment GoalsBusinessCountriesCurrent financingStrong evidence
2015
Defeating AIDS—advancing global health
Piot P, Karim S, Hecht R, Legido-Quigley H, Buse K, Stover J, Resch S, Ryckman T, Møgedal S, Dybul M, Goosby E, Watts C, Kilonzo N, McManus J, Sidibé M, Commission U. Defeating AIDS—advancing global health. The Lancet 2015, 386: 171-218. PMID: 26117719, DOI: 10.1016/s0140-6736(15)60658-4.Peer-Reviewed Original ResearchFunding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries
Resch S, Ryckman T, Hecht R. Funding AIDS programmes in the era of shared responsibility: an analysis of domestic spending in 12 low-income and middle-income countries. The Lancet Global Health 2015, 3: e52-e61. PMID: 25539970, DOI: 10.1016/s2214-109x(14)70342-0.Peer-Reviewed Original ResearchConceptsDomestic spendingRecipient country governmentsLow-income countriesCapacity of countriesEconomic growthDomestic expenditureHealth spendingCountry governmentsFinancing requirementsFunding gapFinancial agreementsFunding requirementsSpendingDonor fundsMiddle-income countriesIncome countriesDomestic sourcesNational governmentsDonor supportCountriesDonor contributionsNational prioritisationAvailable fundingGovernmentFunding partners
2014
Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries
Saxenian H, Hecht R, Kaddar M, Schmitt S, Ryckman T, Cornejo S. Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries. Health Policy And Planning 2014, 30: 197-205. PMID: 24510369, PMCID: PMC4325534, DOI: 10.1093/heapol/czu003.Peer-Reviewed Original Research
2012
Financing vaccinations – The South African experience
Blecher MS, Meheus F, Kollipara A, Hecht R, Cameron NA, Pillay Y, Hanna L. Financing vaccinations – The South African experience. Vaccine 2012, 30: c79-c86. PMID: 22939027, DOI: 10.1016/j.vaccine.2012.04.042.Peer-Reviewed Original ResearchConceptsNew vaccinesNew vaccinationsNational vaccination policyBurden of diseaseHealth Economic CriteriaNew generation vaccinesNational advisory groupDepartment of HealthRotavirus diarrheaPneumococcal diseaseVaccination policyVaccinationGeneration vaccinesVaccineGlobal guidelinesEarly introductionInitial donationNumber of livesDiseaseInternational expertsAdvisory GroupFivefold increaseHealthNational spendingMorbidity
2011
Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries
Resch S, Korenromp E, Stover J, Blakley M, Krubiner C, Thorien K, Hecht R, Atun R. Economic Returns to Investment in AIDS Treatment in Low and Middle Income Countries. PLOS ONE 2011, 6: e25310. PMID: 21998648, PMCID: PMC3187775, DOI: 10.1371/journal.pone.0025310.Peer-Reviewed Original ResearchConceptsMiddle-income countriesAIDS treatmentProgram costsIncome countriesLarge health gainsAntiretroviral therapyHIV infectionOpportunistic infectionsGlobal FundLife careMedical treatmentAIDS diseaseTreatment programHealth gainsCurrent cohortTotal program costsTreatmentPatientsCohortInfectionCareEnd 2011Same periodEconomic benefitsLabor productivity effects
2010
Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31
Hecht R, Stover J, Bollinger L, Muhib F, Case K, de Ferranti D. Financing of HIV/AIDS programme scale-up in low-income and middle-income countries, 2009–31. The Lancet 2010, 376: 1254-1260. PMID: 20934597, DOI: 10.1016/s0140-6736(10)61255-x.Peer-Reviewed Original ResearchConceptsMiddle-income countriesLong-term funding needsLow-income countriesHIV/AIDS fundingOutside fundsPolicy choicesFunding needsStrategic investmentsEfficiency gainsEfficient mobilisationRepresentative countriesAIDS fundingCountriesFundsRange of scenariosShort termGlobal HIV/AIDS pandemicHIV/AIDS programsCostHIV/AIDS responseManagement of resourcesSubstantial variationFinancingInvestmentHIV/AIDS
2009
Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic
Hecht R, Bollinger L, Stover J, McGreevey W, Muhib F, Madavo CE, de Ferranti D. Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic. Health Affairs 2009, 28: 1591-1605. PMID: 19887401, DOI: 10.1377/hlthaff.28.6.1591.Peer-Reviewed Original Research
2007
The Impact Of An AIDS Vaccine In Developing Countries: A New Model And Initial Results
Stover J, Bollinger L, Hecht R, Williams C, Roca E. The Impact Of An AIDS Vaccine In Developing Countries: A New Model And Initial Results. Health Affairs 2007, 26: 1147-1158. PMID: 17630459, DOI: 10.1377/hlthaff.26.4.1147.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAIDS VaccinesDeveloping CountriesDisease SusceptibilityDrug EvaluationFemaleHIV InfectionsHumansIncidenceMaleMiddle AgedModels, StatisticalPatient SelectionProbabilityResearch Support as TopicRisk AssessmentRisk FactorsRisk-TakingSexual BehaviorSubstance Abuse, Intravenous